Share via:
PharmEasy will raise fresh proceeds via NCD’s by pledging the shares of its listed diagnostic company Thyrocare
PharmEasy will use the fresh funds to clear the earlier debt which it raised via NCDs, with total outstanding redemption value of INR 1,820 Cr, of which the current outstanding is INR 1,545.4 Cr
This comes at a time when PharmEasy continues to struggle with profitability and has seen many leadership changes in recent times
API Holdings, the parent company of
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
PharmEasy will raise fresh proceeds via NCD’s by pledging the shares of its listed diagnostic company Thyrocare
PharmEasy will use the fresh funds to clear the earlier debt which it raised via NCDs, with total outstanding redemption value of INR 1,820 Cr, of which the current outstanding is INR 1,545.4 Cr
This comes at a time when PharmEasy continues to struggle with profitability and has seen many leadership changes in recent times
API Holdings, the parent company of
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
